Literature DB >> 17435073

Management of end stage heart failure.

Erik B Friedrich1, Michael Böhm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17435073      PMCID： PMC1955535          DOI： 10.1136/hrt.2006.098814

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  37 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Is the prognosis of heart failure improving?

Authors:  J G Cleland; I Gemmell; A Khand; A Boddy
Journal:  Eur J Heart Fail       Date:  1999-08       Impact factor: 15.534

3.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

Review 4.  [Drug treatment of chronic heart failure].

Authors:  M Böhm; N Werner; M Kindermann
Journal:  Clin Res Cardiol       Date:  2006       Impact factor: 5.460

5.  A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

Authors:  J N Cohn; G Tognoni
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

6.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.

Authors:  M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

7.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

Review 8.  Systematic review of the management of atrial fibrillation in patients with heart failure.

Authors:  A U Khand; A C Rankin; G C Kaye; J G Cleland
Journal:  Eur Heart J       Date:  2000-04       Impact factor: 29.983

9.  Selection and management of ventricular assist device patients: the Muenster experience.

Authors:  M C Deng; M Weyand; D Hammel; C Schmid; S Kerber; C Schmidt; G Breithardt; H H Scheld
Journal:  J Heart Lung Transplant       Date:  2000-08       Impact factor: 10.247

10.  Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

Authors:  J M Brophy; L Joseph; J L Rouleau
Journal:  Ann Intern Med       Date:  2001-04-03       Impact factor: 25.391
View more
  22 in total

1.  Authors' reply concerning the letter by Ensminger et al.

Authors:  Michael Weis; Gerhard Steinbeck; Bruno Reichart; Tassilo Hübner; Thomas Nickel; Steffen Massberg; Rene Schramm; Christian Hagl; Axel Kiwi
Journal:  Clin Res Cardiol       Date:  2015-09-08       Impact factor: 5.460

Review 2.  Stem cells: An eventual treatment option for heart diseases.

Authors:  Joseph C Bilgimol; Subbareddy Ragupathi; Lakshmanan Vengadassalapathy; Nathan S Senthil; Kalimuthu Selvakumar; M Ganesan; Sadananda Rao Manjunath
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

Review 3.  A Systematic Review of Relaxation, Meditation, and Guided Imagery Strategies for Symptom Management in Heart Failure.

Authors:  Kristine L Kwekkeboom; Lisa C Bratzke
Journal:  J Cardiovasc Nurs       Date:  2016 Sep-Oct       Impact factor: 2.083

4.  Referral Criteria to Palliative Care for Patients With Heart Failure: A Systematic Review.

Authors:  Yuchieh Kathryn Chang; Holland Kaplan; Yimin Geng; Li Mo; Jennifer Philip; Anna Collins; Larry A Allen; John A McClung; Martin A Denvir; David Hui
Journal:  Circ Heart Fail       Date:  2020-09-09       Impact factor: 8.790

5.  Hospice Enrollment in Patients With Advanced Heart Failure Decreases Acute Medical Service Utilization.

Authors:  Cindi K Yim; Yolanda Barrón; Stanley Moore; Chris Murtaugh; Anuradha Lala; Melissa Aldridge; Nathan Goldstein; Laura P Gelfman
Journal:  Circ Heart Fail       Date:  2017-03       Impact factor: 8.790

6.  Transcatheter Mitral Valve Repair for Severe,Symptomatic Mitral Regurgitation in Patients with Left Ventricular Assist Devices.

Authors:  Deepa Raghunathan; Ayush Arora; Wahaj Aman; Sriram Nathan; Marwan Jumean; Igor D Gregoric; Biswajit Kar
Journal:  Methodist Debakey Cardiovasc J       Date:  2021-04-05

Review 7.  Evidence of clinical efficacy of counterpulsation therapy methods.

Authors:  M Capoccia; C T Bowles; J R Pepper; N R Banner; A R Simon
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

8.  A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients.

Authors:  Scott T Benken; Nicholas Tillman; Suhuir Dajani; Aesha Shah; Toby Thomas
Journal:  J Cardiothorac Surg       Date:  2014-03-21       Impact factor: 1.637

Review 9.  Bio-artificial heart as ultimate treatment of end-stage heart failure.

Authors:  Francis E Smit; Pascal M Dohmen
Journal:  Med Sci Monit Basic Res       Date:  2014-10-16

10.  Symptom clusters and quality of life among patients with advanced heart failure.

Authors:  Doris Sf Yu; Helen Yl Chan; Doris Yp Leung; Elsie Hui; Janet Wh Sit
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.